Basal activation of type i interferons (alpha2 and beta) and 2 ′ 5 ′ OAS genes: Insights into differential expression profiles of interferon system components in systemic sclerosis

International Journal of Rheumatology

Volumn 2011, Issue , 2011, Pages

  Oliveira, Danilo Bretas De ^a   Almeida, Gabriel Magno De Freitas ^a   Guedes, Antnio Carlos Martins ^a   Santos, Flávia Patrícia Sena Teixeira ^a   Bonjardim, Claudio Antnio ^a   Ferreira, Paulo César Peregrino ^a   Kroon, Erna Geessien ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; BETA INTERFERON; INTERFERON REGULATORY FACTOR 7; RNA;

2'5'OAS GENE; ADULT; AGED; ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; HUMAN; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SYSTEMIC SCLEROSIS; VERO CELL;

EID: 84855289550     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2011/275617     Document Type: Article

References (33)

1. Steen V. D., Systemic sclerosis Rheumatic Disease Clinics of North America 1990 16 3 641 654 (Pubitemid 20330590)
2. Sontheimer R. D., Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics Best Practice and Research: Clinical Rheumatology 2004 18 3 429 462 (Pubitemid 38950060)
3. Denton C. P., Black C. M., Sclerodermaclinical and pathological advances Best Practice and Research: Clinical Rheumatology 2004 18 3 271 290
4. Chizzolini C., Brembilla N. C., Montanari E., Truchetet M. E., Fibrosis and immune dysregulation in systemic sclerosis Autoimmunity Reviews 2010 10 5 276 281
5. Abraham D. J., Varga J., Scleroderma: from cell and molecular mechanisms to disease models Trends in Immunology 2005 26 11 587 595 (Pubitemid 41726446)
6. Rose N. R., Leskovsek N., Scleroderma: immunopathogenesis and treatment Immunology Today 1998 19 11 499 501 (Pubitemid 28518026)
7. Tahara H., Kojima A., Hirokawa T., Oyama T., Naganuma A., Maruta S., Okada K., Ban S., Yoshida K., Takagi H., Mori M., Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C Internal Medicine 2007 46 8 473 476 (Pubitemid 46629944)
8. Assassi S., Mayes M. D., Arnett F. C., Gourh P., Agarwal S. K., McNearney T. A., Chaussabel D., Oommen N., Fischbach M., Shah K. R., Charles J., Pascual V., Reveille J. D., Tan F. K., Systemic sclerosis and lupus: points in an interferon-mediated continuum Arthritis and Rheumatism 2010 62 2 589 598
9. Allanore Y., Borderie D., Hilliquin P., Hernvann A., Levacher M., Lemaréchal H., Ekindjian O. G., Kahan A., Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells Rheumatology 2001 40 10 1089 1096
10. Coelho L. F. L., de Oliveira J. G., Kroon E. G., Interferons and scleroderma-A new clue to understanding the pathogenesis of scleroderma? Immunology Letters 2008 118 2 110 115
11. Sakkas L. I., Tourtellotte C., Berney S., Myers A. R., Platsoucas C. D., Increased levels of alternatively spliced interleukin 4 (IL-4 2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis Clinical and Diagnostic Laboratory Immunology 1999 6 5 660 664 (Pubitemid 29441169)
12. Molteni M., Della Bella S., Mascagni B., Bazzi S., Zulian C., Compasso S., Lessi M., Scorza R., Increased interferon-gamma (IFN- ) levels produced in vitro by alloactivated T lymphocytes in systemic sclerosis and Raynaud's phenomenon Clinical and Experimental Immunology 1999 116 1 164 168 (Pubitemid 29170020)
13. Yamamoto T., Katayama I., Nishioka K., Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis Journal of Rheumatology 1998 25 2 314 317 (Pubitemid 28088261)
14. Ihn H., Sato S., Fujimoto M., Kikuchi K., Kadono T., Tamaki K., Takehara K., Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines British Journal of Rheumatology 1997 36 12 1270 1275
15. Valentini G., Baroni A., Esposito K., Naclerio C., Buommino E., Farzati A., Cuomo G., Farzati B., Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation Journal of Clinical Immunology 2001 21 3 210 217 (Pubitemid 32434308)
16. Kontsek P., Karayianni-Vasconcelos G., Kontsekov E., The human interferon system: characterization and classification after discovery of novel members Acta Virologica 2003 47 4 201 215 (Pubitemid 38186083)
17. Pestka S., Krause C. D., Walter M. R., Interferons, interferon-like cytokines, and their receptors Immunological Reviews 2004 202 8 32 (Pubitemid 39576902)
18. Banchereau J., Pascual V., Type I interferon in systemic lupus erythematosus and other autoimmune diseases Immunity 2006 25 3 383 392 (Pubitemid 44354221)
19. Coelho L. F. L., de Oliveira J. G., de Oliveira D. B., Guedes A. C. M., Lanna C. C. D., Prados R. Z., Ferreira P. C. P., Bonjardim C. A., Kroon E. G., Increased expression of 2′5′oligoadenylate synthetase and double-stranded RNA dependent protein kinase messenger RNAs on affected skin of systemic sclerosis patients Archives of Dermatological Research 2007 299 5-6 259 262 (Pubitemid 47222916)
20. Theofilopoulos A. N., Baccala R., Beutler B., Kono D. H., Type I interferons ( / ) in immunity and autoimmunity Annual Review of Immunology 2005 23 307 336
21. Hikami K., Ehara Y., Hasegawa M., Fujimoto M., Matsushita M., Oka T., Takehara K., Sato S., Tokunaga K., Tsuchiya N., Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis Biochemical and Biophysical Research Communications 2008 373 3 403 407
22. Crow M. K., Kirou K. A., Interferon-induced versus chemokine transcripts as lupus biomarkers Arthritis Research and Therapy 2008 10 6, article 126
23. Farina G., Lafyatis D., Lemaire R., Lafyatis R., A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis Arthritis and Rheumatism 2010 62 2 580 588
24. Tan F. K., Zhou X., Mayes M. D., Gourh P., Guo X., Marcum C., Jin L., Arnett F. C., Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients Rheumatology 2006 45 6 694 702 (Pubitemid 43985337)
25. Christmann R. B., Hayes E., Pendergrass S., Padilla C., Farina G., Affandi A. J., Whitfield M. L., Farber H. W., Lafyatis R., Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension Arthritis and Rheumatism 2011 63 6 1718 1728
26. Byum A., Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g Scandinavian Journal of Clinical and Laboratory Investigation 1968 97 77 89
27. Ferreira P. C. P., Peixoto M. L. P., Silva M. A. V., Golgher R. R., Assay of human interferon in Vero cells by several methods Journal of Clinical Microbiology 1979 9 4 471 475 (Pubitemid 9157627)
28. Marijanovic Z., Ragimbeau J., van der Heyden J., Uzé G., Pellegrini S., Comparable potency of IFN 2 and IFN on immediate JAK/STAT activation but differential down-regulation of IFNAR2 Biochemical Journal 2007 407 1 141 151 (Pubitemid 47535589)
29. Osterlund P. I., Pietila T. E., Veckman V., Kotenko S. V., Julkunen I., IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes Journal of Immunology 2007 179 6 3434 3442
30. Ye S., Guo Q., Tang J. P., Yang C. D., Shen N., Chen S. L., Could 2′5′ -oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study Clinical Rheumatology 2007 26 2 186 190 (Pubitemid 46020241)
31. Eloranta M. L., Franck-Larsson K., Lvgren T., Kalamajski S., Rnnblom A., Rubin K., Alm G. V., Rnnblom L., Type I interferon system activation and association with disease manifestations in systemic sclerosis Annals of the Rheumatic Diseases 2010 69 7 1396 1402
32. Marshak-Rothstein A., Toll-like receptors in systemic autoimmune disease Nature Reviews Immunology 2006 6 11 823 835 (Pubitemid 44631651)
33. Agarwal S. K., Wu M., Livingston C. K., Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts Arthritis Research and Therapy 2011 13 1, article 3